{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 13,
        "end": 24
      }
    },
    {
      "id": "T2",
      "obj": "Chemical",
      "span": {
        "begin": 29,
        "end": 39
      }
    },
    {
      "id": "T3",
      "obj": "Disease",
      "span": {
        "begin": 163,
        "end": 171
      }
    },
    {
      "id": "T5",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 176,
        "end": 180
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "26056325_2",
  "text": "UNASSIGNED : Vemurafenib and dabrafenib are both orally bioavailable small molecule agents that block mitogen activated protein kinase signalling in patients with melanoma and BRAF (V600E ) mutation ."
}
